Trial NCT01018810

View at ClinicalTrials.gov 
Org. Study IDs: 11431
Secondary IDs: I1X-MC-BDAD

Last trial update was posted on 2011-07-29

MeSH Interventions

Antibodies Immunoglobulins Interleukin-23

MeSH Conditions

Psoriasis

Other Conditions


Stopping Reasons

The trial was terminated for several reasons, including complexities in development of LY2525623, but not because of safety concerns

Limitations And Caveats

Study BDAD was terminated early due to non-safety related complexities in LY2525623 development. Numerical summaries and statistical comparisons for the 8 patients enrolled are not appropriate and may be scientifically/clinically misleading.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID